Ballicules.com

Diphenhydramine injection

BENADRYL IM / IV

What it isInjectable H1 and muscarinic antagonist; allergic reactions and acute dystonia or parkinsonism.

Why this oneThe B-52 ingredient: anticholinergic cover against haloperidol dystonia while it sedates.

What limits itSedation, delirium, urinary retention, and hypotension make its anticholinergic burden especially hazardous in older adults.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Allergic reactions/anaphylaxis adjunct, motion sickness, parkinsonism (when oral impractical)Adults10–50 mg IV/IM (up to 100 mg if required)400 mg/day
Allergic reactions, motion sickness, parkinsonism (when oral impractical)Pediatric (not neonates/premature infants)5 mg/kg/day or 150 mg/m²/day IV/IM divided into 4 doses300 mg/day

Renal Undefined.

Hepatic Undefined.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined.

Lactation Contraindicated in nursing mothers (higher antihistamine risk for infants).

NO BOXED WARNINGS

Principal riskAnticholinergic burden; on every elderly deprescribing list

Classes and tags

Clinical profile

Direct muscarinic antagonism3 / 4

Mechanism of action: Diphenhydramine injection ballicule

Diphenhydramine injection ballicule: receptor binding, kinetics and half-life diagram

Open Diphenhydramine injection in the interactive console ↗